Clinical Study

Urate Lowering Therapy with Febuxostat in Daily Practice—A Multicentre, Open-Label, Prospective Observational Study

Figure 2

Percentage of patients who reached the individual target value of 6 mg/dL (0 0.5 mg/dL), respectively, who had lower (−1 to >−5 mg/dL) or higher (+1 to >+5 mg/dL) uric acid values. Note that about one-third (29.6%) failed to reach the guideline recommended target [6, 8].
123105.fig.002